January 26, 2012
How well is the network equipment sector faring? We'll know a little more when Riverbed Technology (Nasdaq: RVBD ) reports fourth-quarter earnings after the bell today. Here's a closer look at what analysts expect from this Motley Fool Rule Breakers recommendation:
Q4 2011 (est.)
|Earning per Share
Source: Yahoo! Finance.
Let's hope Wall Street is lowballing. According to S&P Capital IQ, Riverbed's revenue growth has decelerated quarter over quarter for four quarters running prior to today's report. Slowing sales growth could dampen a recent run of investor enthusiasm.
3 more things to watch
As business-focused investors, there are several Riverbed initiatives we're interested in. Here are three things I'm particularly hoping to hear more about:
- Pipeline progress. Orders for Riverbed's Steelhead appliances tend to run in the tens of thousands of dollars, and thus can be difficult to close in a timely manner. How well did Riverbed manage its backlog this quarter? Are sales closing in a timely manner?
- Market share. Despite competitive pressure from Cisco Systems (Nasdaq: CSCO ) and one-offs such as F5 Networks (Nasdaq: FFIV ) , Riverbed controlled more than half the share of its primary market as of October. At the time, the report reflected an ongoing trend of Riverbed capturing share from rivals. Is that still the case?
- Whitewater. What Steelhead is to accelerating the delivery of content over a wide area network, Whitewater is to optimizing the archiving process inside a storage network. The settings may be different, but the essential deduplication algorithms for lightening data as it travels remain the same. Is management's plan resonating with customers?
Those are my questions. Now it's your turn to weigh in. What do you expect to hear from Riverbed Technology today? Let us know by leaving a comment below.
And if you're in the market for more Rule Breaking stocks, take note: The Motley Fool recently released a report entitled "Discovering the Next Rule-Breaking Multibagger," which profiles a health-care innovator preparing to break out. Click here to get full access now -- the research is 100% free for a limited time.
Click here to add Riverbed Technology to My Watchlist for up-to-the-minute Foolish coverage of the stock and your entire portfolio.